STTK - Shattuck Labs, Inc.
0.8724
0.002 0.264%
Share volume: 73,328
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.87
0.00
0.00%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 08-10-2023 | 11-09-2023 | 02-29-2024 | 05-02-2024 | 08-01-2024 | 11-14-2024 | 03-27-2025 | 05-01-2025 | |
| Total revenue | 200.000 K | 686.000 K | 714.000 K | 1.115 M | 1.609 M | 2.997 M | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 200.000 K | 686.000 K | 714.000 K | 1.115 M | 1.609 M | 2.997 M | 0.000 | 0.000 | |
| 243.00% | 4.08% | 56.16% | 44.30% | 86.26% | -100.00% | ||||
| Operating expenses | 22.947 M | 29.284 M | 19.665 M | 21.159 M | 24.571 M | 20.917 M | 19.641 M | 14.389 M | |
| Selling general and admin | 4.742 M | 5.073 M | 4.438 M | 4.895 M | 5.332 M | 4.604 M | 4.246 M | 4.470 M | |
| Research and development | 18.205 M | 24.211 M | 15.227 M | 16.264 M | 19.239 M | 16.313 M | 15.395 M | 9.919 M | |
| Total expenses | 22.947 M | 29.284 M | 19.665 M | 21.159 M | 24.571 M | 20.917 M | 19.641 M | 14.389 M | |
| 27.62% | -32.85% | 7.60% | 16.13% | -14.87% | -6.10% | -26.74% | |||
| Operating income | -22.747 M | -28.598 M | -18.951 M | -20.044 M | -22.962 M | -17.920 M | -19.641 M | -14.389 M | |
| Ebit | -22.747 M | -28.598 M | -18.951 M | -20.044 M | -22.962 M | -16.675 M | -23.853 M | -13.702 M | |
| Pretax income | -21.346 M | -27.541 M | -17.687 M | -18.504 M | -21.552 M | -16.675 M | -18.679 M | -13.702 M | |
| 29.02% | -35.78% | 4.62% | 16.47% | -22.63% | 12.02% | -26.64% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -21.346 M | -27.541 M | -17.687 M | -18.504 M | -21.552 M | 0.000 | 0.000 | 0.000 | |
| -29.02% | 35.78% | -4.62% | -16.47% | 100.00% | |||||
| Net income | -21.346 M | -27.541 M | -17.687 M | -18.504 M | -21.552 M | -16.675 M | -18.679 M | -13.702 M | |
| -29.02% | 35.78% | -4.62% | -16.47% | 22.63% | -12.02% | 26.64% |
